In relation to this, our study participants, who have a median age of 60 and are in the early stages of diabetes progression, may represent a more insulin resistant phenotype in which the functional β-cell machinery is still able to compensate for diminishing insulin sensitivity. The gene discussed is INS; the disease is diabetes mellitus.